These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4675065)

  • 1. [The effect of cytosine arabinoside on cell kinetics in adult acute leukemia and its correlation to the therapeutic response].
    Furusawa S; Adachi Y; Nomura T; Komiya M
    Rinsho Ketsueki; 1972 Dec; 13(6):943-50. PubMed ID: 4675065
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cell cycle effect of cytosine arabinoside, vincristine, and massive leukapheresis on human leukemic blasts and its application to a quadruple combination chemotherapy of acute leukemia (author's transl)].
    Yoshikawa H; Takeyama H; Nagata K; Ueda R; Ishiguro J
    Rinsho Ketsueki; 1975 Jan; 16(1):8-18. PubMed ID: 1172041
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effects of cytosine arabinoside and daunomycin on cell kinetics in childhood acute myeloblastic leukemia].
    Tsukimoto I; Toyosaka H; Tashiro Y; Nagao T
    Rinsho Ketsueki; 1973 Jul; 14(7):762-8. PubMed ID: 4517365
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytosine arabinoside. Results of a cooperative study in acute childhood leukemia.
    Howard JP; Albo V; Newton WA
    Cancer; 1968 Mar; 21(3):341-5. PubMed ID: 5637945
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro proliferation of leukemic blast cells and response to daunorubidomycin-cytosine arabinoside].
    Huber H; Huber CH; Michlmayr G; Asamer H; Braunsteiner H
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1785-7. PubMed ID: 5140917
    [No Abstract]   [Full Text] [Related]  

  • 6. [Abnormalities of the erythropoiesis at the beginning of remission in acute promyelocytic leukemia treated with arabinoside-cytosine].
    Dubois-Ferrière H; Aguercif M; Hazeghi P; Rudhardt M
    Schweiz Med Wochenschr; 1970 Feb; 100(7):321-3. PubMed ID: 5263342
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quadruple combination chemotherapy of acute leukemia using daunomycin, cytosine arabinoside, 6-mercaptopurine riboside and prednisolone].
    Hirano M; Morita A; Sako F; Uetani T; Koie K
    Rinsho Ketsueki; 1972 Dec; 13(6):951-7. PubMed ID: 4675066
    [No Abstract]   [Full Text] [Related]  

  • 8. Perturbation of cell cycle of human leukaemic myeloblasts in vivo by cytosine arabinoside.
    Ernst P; Faille A; Killmann SA
    Scand J Haematol; 1973; 10(3):209-18. PubMed ID: 4520466
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical application of bone marrow culture from patients with acute leukemia.
    Raab MJ; Anderson C; Raab SO
    J Ark Med Soc; 1976 Jul; 73(2):94-6. PubMed ID: 133099
    [No Abstract]   [Full Text] [Related]  

  • 10. [Low-dose cytosine arabinoside therapy in relapsed acute leukemia: correlation of clinical response and in vitro sensitivity tests].
    Ninomiya T; Hirose M; Takaue Y; Watanabe T; Ouchi T; Sato J; Koyama T; Abe T; Suzue T
    Rinsho Ketsueki; 1987 Oct; 28(10):1763-70. PubMed ID: 3452642
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cytostatic drugs on the kinetics of leukemic blast cells in man.
    Killmann SA
    Schweiz Med Wochenschr; 1974 Feb; 104(8):278-84. PubMed ID: 4814680
    [No Abstract]   [Full Text] [Related]  

  • 12. [High-dose cytosine arabinoside in acute leukemia: a cooperative study].
    Urabe A; Takaku F; Mizoguchi H; Yamada O; Wakabayashi Y; Miura Y; Sakamoto S; Yoshida M; Miwa S; Asano S
    Rinsho Ketsueki; 1985 Feb; 26(2):184-8. PubMed ID: 3894715
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytokinetic effect of cytosine arabinoside in clinical tests].
    Barlogie B; Büchner T; Asseburg U; Kamanabroo D
    Med Welt; 1974 Sep; 25(39):1532-4. PubMed ID: 4530133
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug effect in acute leukemia.
    Lampkin BC; Nagao T; Mauer AM
    J Clin Invest; 1969 Jun; 48(6):1124-30. PubMed ID: 5253748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Induction of cellular differentiation in the treatment of acute leukemias: preliminary report of the use of low doses of cytosine arabinoside for the induction of remission].
    Marín-López A; Lobato-Mendizábal E; Munive-Ordóñez I; Ruiz-Argüelles GJ
    Rev Invest Clin; 1984; 36(3):247-51. PubMed ID: 6515157
    [No Abstract]   [Full Text] [Related]  

  • 16. [High-dose cytosine arabinoside therapy in refractory acute leukemia].
    Yorimitsu S; Takahashi I; Kitazima K; Kimura I; Hara M; Tokuda M
    Rinsho Ketsueki; 1984 Dec; 25(12):1941-6. PubMed ID: 6533329
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytosine arabinoside as a polyvalent drug in the treatment of acute non-lymphoid leukemias].
    Sánchez Fayos J
    Sangre (Barc); 1986; 31(5):566-73. PubMed ID: 3810411
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical evaluation of dose and schedule of administration of cytosine arabinoside (NSC 63878).
    Burke PJ; Serpick AA; Carbone PP; Tarr N
    Cancer Res; 1968 Feb; 28(2):274-9. PubMed ID: 4868015
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
    Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
    J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.